XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following table represents our revenues disaggregated by product line (in thousands):

Three months ended
September 30,
Nine months ended
September 30,
Product line2024202320242023
Consumables$264,875 $242,010 $770,730 $715,108 
Infusion Systems159,769 148,981 480,745 463,836 
Vital Care164,487 162,320 500,766 492,326 
Total Revenues$589,131 $553,311 $1,752,241 $1,671,270 

For the three and nine months ended September 30, 2024, net sales to Medline made up approximately 18% and 17% of total revenues, respectively. For the three and nine months ended September 30, 2023, net sales to Medline made up approximately 18% and 16% of total revenues, respectively.

The following table represents our revenues disaggregated by geography (in thousands):
Three months ended
September 30,
Nine months ended
September 30,
Geography2024202320242023
United States$369,515 $355,984 $1,118,810 $1,063,037 
Europe, the Middle East and Africa101,710 88,014 295,409 276,994 
APAC60,288 59,064 173,365 177,719 
Other Foreign57,618 50,249 164,657 153,520 
Total Revenues$589,131 $553,311 $1,752,241 $1,671,270 
Contract with Customer, Asset and Liability [Table Text Block] The following table presents the changes in our contract balances for the nine months ended September 30, 2024 and 2023 (in thousands), which is included in accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets:
Contract Liabilities
Beginning balance, January 1, 2024$42,177 
Equipment revenue recognized(41,392)
Equipment revenue deferred due to implementation38,825 
Software revenue recognized(23,591)
Software revenue deferred due to implementation24,559 
Government grant income recognized(1)
(1,551)
Government grant income deferred— 
Other deferred revenue503 
Other deferred revenue recognized(2,562)
Ending balance, September 30, 2024
$36,968 
Beginning balance, January 1, 2023$45,866 
Equipment revenue recognized(24,872)
Equipment revenue deferred due to implementation25,620 
Software revenue recognized(13,546)
Software revenue deferred due to implementation12,797 
Government grant income deferred944 
Government grant income recognized(1)
(3,164)
Other deferred revenue1,674 
Other deferred revenue recognized(4,748)
Ending balance, September 30, 2023
$40,571 
Deferred Revenue, by Arrangement, Disclosure
As of September 30, 2024, revenue from remaining performance obligations is as follows:

Recognition Timing
(in thousands)< 12 Months> 12 Months
Equipment deferred revenue$14,641 $1,713 
Software deferred revenue10,185 459 
Government grant deferred income(1)
2,064 7,864 
Other deferred revenue(2)
42 — 
Total $26,932 $10,036 
_________________________________
(1) The government grant deferred income is amortized over the life of the related depreciable asset as a reduction to depreciation expense.
(2) Other deferred revenue includes pump development programs, purchased training and extended warranty.